Filament Health Corp. (NEO:FH)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Psychedelic Medicines	2.13M
Psychedelic Medicines Growth	484.63%

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Canada	2.13M
Canada Growth	484.63%